• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

The Stock Market Is Facing One Big Obstacle Right Now

You have to wonder how much longer we can run without a pullback of at least 2%.
By JAMES "REV SHARK" DEPORRE
Jan 19, 2018 | 12:00 PM EST
Stocks quotes in this article: IBM, AXP, GBT, APTI, IOVA, MDGL, GSUM, CMCM, REDU

Given the news flow the indices have been holding up quite well but they are starting to slip a bit more as the government shutdown issue drags out. Both IBM (IBM) and American Express (AXP) have failed to bounce back from early pressure, so that isn't helping matters either.

The biggest obstacle the market faces at this juncture is that it is technically extended. The strong momentum has offset that problem but it is a battle of attrition. Pockets of momentum are narrowing and the inclination to protect profits is growing.

Breadth is running nicely at better than 2 to 1 positive and I'm seeing some notable strength in the biotechnology sector, particularly as names such as Global Blood Therapeutics (GBT) , Apptio (APTI) , Iovance Biotherapeutics (IOVA) and Madrigal Pharmaceuticals (MDGL) are trading strongly.

I also see some strong moves from good bases in Gridsum Holding (GSUM) , Cheetah Mobile (CMCM) and RISE Education Cayman Ltd. (REDU) .

You have to wonder how much longer this market can run without a pullback of at least 2%. Nevertheless, you can't pass up good technical action in individual stocks because of the overbought indices. I still see quite a few good long setups and until that changes I'll stay bullish.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark was long APTI, GBT, IOVA, GSUM, CMCM and REDU.

TAGS: Investing | U.S. Equity | Healthcare | Markets | How-to | Politics | Stocks

More from Healthcare

CVS' Massive M&A Moves Spark Skepticism on the Stock

Kevin Curran
Feb 20, 2019 4:10 PM EST

CVS' spending spree has developed a deep debt issue for the company.

Chart of the Day: Is CVS Stock Too Cheap to Ignore?

Kevin Curran
Feb 20, 2019 2:06 PM EST

Is CVS open to those seeking value?

Trump Administration Is No Friend to Pharmacy Benefit Managers Like CVS

Kevin Curran
Feb 20, 2019 12:09 PM EST

Pharmacy Benefit Managers (PBMs) are in for some problems if proposed regulation is given approval.

Anthem Is Pointed Up but Let's Tighten Our Stop Protection

Bruce Kamich
Feb 20, 2019 10:19 AM EST

Sticking to the charts and technical indicators.

3 Small Biotechs to Watch as Earnings Season Winds Down

Bret Jensen
Feb 20, 2019 9:12 AM EST

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:42 PM EST KEVIN CURRAN

    Kraft Heinz Hits Numerous ETFs

    Even for those avoiding Kraft Heinz stock, contr...
  • 11:11 AM EST KEVIN CURRAN

    KHC Crashes Through Technical Floor, Options Action Accelerates

    The RSI on Kraft Heinz is reflecting a shockingl...
  • 11:48 AM EST BOB LANG

    Making a Case for Microsoft and Snap

    Mr Softy has long been a laggard and late to the p...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login